Heron Therapeutics | HRTX - القيمة السوقية





القيمة السوقية تغيير تاريخ
ALKERMES USD 7.93B 806M 2026-08
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amarin USD 290M 51M 2025-12
ANI Pharmaceuticals USD 1.59B 293M 2026-08
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 10.84B 664M 2026-08
Eisai JPY 1.2T 219.32B 2026-06
Emergent BioSolutions USD 125M 51M 2023-12
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 19.68B 3.43B 2026-08
Ligand Pharmaceuticals USD 5.31B 1.02B 2026-08
Merck USD 324.18B 6.81B 2026-08
Nektar Therapeutics USD 12.98B 10.86B 2026-08
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Pacira USD 1.28B 286M 2026-08
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Veracyte USD 4.69B 2.12B 2026-06
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08